ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 43 filers reported holding ATYR PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 682 | $1,078 | 0.00% |
| UBS Group AG | 4,399 | $6,950 | 0.00% |
| Cubist Systematic Strategies, LLC | 11,961 | $18,898 | 0.00% |
| JPMORGAN CHASE & CO | 49,642 | $78,434 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 92,332 | $145,885 | 0.00% |
External links
This page lists ATYR PHARMA INC's shareholders in Q3 2023. To view ATYR PHARMA INC's shareholder history, click here.